Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis

The COVID-19 pandemic has redemonstrated the importance of the fungal-after-viral phenomenon, and the question of whether prophylaxis should be used to prevent COVID-19-associated pulmonary aspergillosis (CAPA). A distinct pathophysiology from invasive pulmonary aspergillosis (IPA), CAPA has an inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawes, Armani M., Permpalung, Nitipong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774425/
https://www.ncbi.nlm.nih.gov/pubmed/36551361
http://dx.doi.org/10.3390/antibiotics11121704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774425/
https://www.ncbi.nlm.nih.gov/pubmed/36551361
http://dx.doi.org/10.3390/antibiotics11121704

Ejemplares similares